Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2017 16:31 ET | Source: INC Research, LLC

INC Research/inVentiv Health to Present at Upcoming Jefferies 2017 London Healthcare Conference

RALEIGH, N.C., Nov. 03, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive...
October 19, 2017 17:02 ET | Source: INC Research, LLC

INC Research/inVentiv Health Schedules Third Quarter 2017 Earnings Call for Thursday, November 9, 2017

RALEIGH, N.C., Oct. 19, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully-integrated biopharmaceutical solutions organization combining a CRO and CCO (Contract...
October 10, 2017 11:36 ET | Source: INC Research, LLC

Investigative Sites Honor INC Research/inVentiv Health with 2017 Society for Clinical Research Sites Eagle Award

RALEIGH, N.C., Oct. 10, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully integrated biopharmaceutical solutions organization combining a CRO and CCO (Contract...
August 21, 2017 17:01 ET | Source: INC Research, LLC

INC Research/inVentiv Health to Present at Upcoming September Conferences

RALEIGH, N.C., Aug. 21, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully-integrated biopharmaceutical solutions organization, today announced that Chief Financial...
August 01, 2017 09:12 ET | Source: INC Research, LLC

INC Research and inVentiv Health Announce Successful Completion of Merger

Combination Creates the Only Fully Integrated Biopharmaceutical Solutions Organization with Combined Net Revenue of More Than $3 Billion Relaunch Under New Brand Planned for 2018 RALEIGH, N.C. and...
May 10, 2017 06:03 ET | Source: INC Research, LLC

INC Research and inVentiv Health to Merge

Creates a Leading Global Biopharmaceutical Solutions Organization with Combined Net Revenue of More Than $3.2 Billion Combined Company Will Be Second Largest Biopharmaceutical Outsourcing Provider,...